SCHEMBL13152174

SCHEMBL13152174

BCCCC(=O)Nc1ccc(C#Cc2c(N)c3ccc(OC)cc3n2CC)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 2/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42
MTNR1A P48039 3/20 0.41
MTNR1B P49286 3/20 0.41
RORC P51449 3/20 0.41
HDAC1 Q13547 4/20 0.40
HDAC3 O15379 3/20 0.40
HDAC2 Q92769 3/20 0.40
HDAC8 Q9BY41 3/20 0.40
HDAC6 Q9UBN7 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
HDAC4 P56524 2/20 0.40
HDAC7 Q8WUI4 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10097782 0.91 L3MBTL1 (0.42) L3MBTL1MAPTALDH1A1CYP1A2CYP3A4
SCHEMBL13152055 0.89 MTNR1A (0.46) MAPTALDH1A1MTNR1AMTNR1BNPC1
SCHEMBL10097656 0.89 PFKFB2 (0.48) MAPTALDH1A1MTNR1AMTNR1BRORC
SCHEMBL13153378 0.88 NPC1 (0.42) MAPTALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL10097607 0.87 MTNR1A (0.46) L3MBTL1MAPTALDH1A1MTNR1AMTNR1B
SCHEMBL13152172 0.84 MAPT (0.44) MAPTALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL10249955 0.82 MTNR1A (0.46) MAPTALDH1A1TSHRMTNR1AMTNR1B
SCHEMBL10256083 0.82 KMT2A (0.50) MAPTALDH1A1MTNR1AMTNR1BRORC
SCHEMBL10249312 0.81 MTNR1A (0.42) MAPTMTNR1AMTNR1BNPC1RAB9A
SCHEMBL10097294 0.81 MAPT (0.41) MAPTALDH1A1MTNR1BNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010118009-A1 HCV INHIBITOR AND THERAPEUTIC AGENT COMBINATIONS PTC THERAPEUTICS, INC. (US) 2010-10-14 WO disclosed